Publication | Open Access
Peripheral CD4+ naïve/memory ratio is an independent predictor of survival in non-small cell lung cancer
25
Citations
20
References
2017
Year
Peripheral CD4+ naïve/memory ratio can be used as a predictive biomarker in NSCLC patients and used to optimize personalized treatment strategies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1